Amicus Therapeutics, Inc. (Jobs) Sets IPO at 5 Million Shares

Published: May 17, 2007

WASHINGTON, May 17 (Reuters) - Biopharmaceutical firm Amicus Therapeutics Inc. on Thursday set its planned initial public offering at 5 million shares for an estimated $14 to $16 each.

>>> Discuss This Story

Back to news